Address
Frankfurter Strasse 250
Darmstadt, 64293
Germany
Phone
49 6151 72 0
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
59020
First IPO Date
June 26, 1998
| Name | Title | Pay | Year Born |
| Jean Charles Wirth | Member of the Executive Board & Chief Executive Officer Life Science | 1.21M | 1973 |
| Danny Pinhas Bar-Zohar | Member of the Executive Board & Chief Executive Officer of Healthcare | 1.22M | 1970 |
| Kai Beckmann | CEO & Chair of Management Board | 4.93M | 1965 |
| Benjamin Hein | Member of Management Board & CEO of Electronics Business Sector | 0 | N/A |
| Khadija Ben Hammada | Member of the Executive Board & Chief People Officer | 1.21M | 1980 |
| Helene von Roeder | Chief Financial Officer & Member of Executive Board | 4.76M | 1970 |
| Belen Garijo Lopez | Executive Officer | 6.71M | 1960 |
| Florian Schraeder | Head of Investor Relations | 0 | N/A |
| Axel Lober | Head of Global Communications | 0 | N/A |
| Marc Horn | Head of Life Science Controlling | 0 | 1975 |
| Frank Gotthardt | Head of Corporate & Government Relations - Europe | 0 | N/A |
Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and various industrial sectors. It also offers specialized process development expertise, such as continuous bioprocessing for drug manufacturers, provides a range of testing kits, reagents, and services, and develops solutions for analyzing environmental samples like air, water, and soil. Furthermore, this segment aids in assessing nutritional value and identifying quality control issues. In its Healthcare segment, the company is involved in the entire lifecycle of prescription drugs and biopharmaceuticals, from initial discovery and development through manufacturing and marketing. Its therapeutic focus areas include oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. This segment also produces general medicines, injection devices, and software for disease monitoring. The Electronics division delivers critical materials for the semiconductor and display industries. It also specializes in surface design, providing delivery systems and services, along with a variety of surface solutions for applications such as cosmetics, effect pigments, and other functional materials. Merck KGaA is also actively engaged in strategic partnerships. These include in-licensing agreements with Debiopharm International SA for developing treatments for head and neck cancer, with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for metastatic colorectal cancer drug candidates, and with Abbisko Therapeutics Co. Ltd. for therapies targeting tenosynovial giant cell tumors. Additionally, the company is involved in collaborations focused on discovering and developing targeted protein degraders against critical oncogenic proteins. Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA operates as a subsidiary of E. Merck KG.